According to an article published by GAVI on April 22, 2025, approved malaria vaccines arrived by Zipline drone, an unmanned mini-plane carrying parachute-equipped cargo in its belly. This innovative technology can drop packages precisely over targeted facilities.
"So far, this initiative has helped to reach 20,000 people with the first dose of the malaria vaccine in the state," said Chinedu Amah, the Sales and Partnership Director for Zipline in Bayelsa state, in GAVI's article.
"Our drones can make the journey in as little as 45 minutes. So it's been a game-changer for the state in its health system, and we've shown a lot of value creation within the state using our drones," Amah added.
According to the World Health Organization (WHO), despite an annual expenditure of $4 billion, malaria deaths and cases have not shown substantial change over the last decade. According to WHO's latest malaria report, there were an estimated 263 million malaria cases and 597,000 related fatalities worldwide in 2023.
This data represents about 11 million more cases than in 2022.
The WHO African Region shoulders the heaviest burden of malaria outbreaks.
Dr Williams of the Bayelsa State Primary Health Care Board told VaccinesWork, "Our (Nigeria) distribution centre, serving hundreds of health facilities and community sites across a 38,000 square-kilometre radius, has drastically reduced stock-outs to below 1%. Deliveries now arrive within 15–45 minutes, regardless of weather or terrain, significantly improving coverage and timeliness."
As of April 23, 2025, the WHO recommends Mosquirix™ and R21 / Matrix-M™ vaccines to prevent this mosquito-transmitted disease for travelers visiting malaria-endemic countries. These malaria vaccines were added to the WHO's list of prequalified vaccines in 2024.
Currently, 17 African countries have introduced malaria vaccines through routine immunization targeting children.
No comments:
Post a Comment